Medicare Enrolled

Dr. Ovidiu Grigoras, M.D., PH.D.

Family Medicine · North Port, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
13815 TAMIAMI TRL, North Port, FL 34287
9414264900
In practice since 2008 (17 years)
NPI: 1437313970 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Grigoras from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grigoras? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Grigoras

Dr. Ovidiu Grigoras is a family medicine in North Port, FL, with 17 years in practice. Based on federal Medicare data, Dr. Grigoras performed 7,356 Medicare services across 4,956 unique beneficiaries.

Between the years covered by Open Payments, Dr. Grigoras received a total of $807 from 13 pharmaceutical and/or device companies across 43 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Grigoras is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 4% volume in FL$ $807 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,356
Medicare services
Top 4% in FL for family medicine
4,956
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~433 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or1,042$24$67
Blood draw (venipuncture)388$8$17
Office visit, established patient, complex (40-54 min)308$120$371
Comprehensive metabolic blood panel274$10$21
Complete blood count (CBC) with differential273$8$16
Lipid panel (cholesterol and triglycerides)250$13$27
Vitamin B-12 level test247$15$30
Folic acid level test247$14$29
Thyroid stimulating hormone (TSH) test238$16$34
Magnesium level test224$7$13
Vitamin D level test221$29$59
Free thyroxine (T4) test219$9$18
Hemoglobin A1c test (diabetes monitoring)216$9$19
Creatine kinase (cardiac enzyme) level, total210$6$13
Urine microalbumin test (kidney screening)206$6$12
Creatinine test (kidney function)206$5$10
Lipase (fat enzyme) level193$7$14
Amylase (enzyme) level190$6$13
Annual wellness visit, follow-up188$125$267
Annual depression screening188$18$38
Automated urinalysis145$2$4
Iron level test137$6$13
Ferritin level test (iron stores)135$13$27
Iron binding capacity test114$9$17
C-reactive protein test (inflammation marker)112$5$10
Uric acid level test110$4$9
Urinalysis with microscopic exam107$3$6
Cortisol (hormone) measurement, total93$16$33
Glutamyltransferase (liver enzyme) level91$7$14
Sed rate test (inflammation marker)61$3$5
Bilirubin level, direct53$5$10
Drug injection, under skin or into muscle51$10$30
Urine culture, bacterial colony count49$8$16
Parathyroid hormone level test46$40$83
Phosphate level test43$5$9
Rheumatoid factor level41$5$11
Office visit, established patient (30-39 min)41$83$264
Prostate cancer screening; prostate specific antigen test (psa)41$19$39
PSA test (prostate cancer screening)38$18$37
Flu vaccine administration38$29$64
Flu vaccine, high-dose37$70$145
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous37$17$36
Basic metabolic blood panel31$8$17
Liver function blood test panel31$8$16
Office visit, established patient (20-29 min)28$68$187
Transferrin (iron binding protein) level22$12$26
Red blood count, manual test21$4$9
Bacterial culture, aerobic18$8$16
Antibiotic sensitivity test18$8$17
Electrocardiogram (EKG), 12-lead17$11$30
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use11$282$577
Pneumonia vaccine administration11$30$64
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$807
Total received (2018-2024)
Avg $134/year across 6 years
Top 39% in FL for family medicine
13
Companies
43
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$807 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$124
2023
$205
2022
$250
2020
$29
2019
$67
2018
$131

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$253
Amgen Inc.
$99
Astellas Pharma US Inc
$82
PFIZER INC.
$74
GlaxoSmithKline, LLC.
$52
Novo Nordisk Inc
$52
Novartis Pharmaceuticals Corporation
$48
Boston Scientific Corporation
$45
Janssen Pharmaceuticals, Inc
$28
Philips Electronics North America Corporation
$26
Merck Sharp & Dohme LLC
$16
Merck Sharp & Dohme Corporation
$16
SANOFI PASTEUR INC.
$15
Top 3 companies account for 53.8% of total payments
Associated products mentioned in payments ›
ANORO · BELSOMRA · BREO · CHANTIX · ELIQUIS · ENTRESTO · EVENITY · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · JANUVIA · LEQVIO · LYRICA · MYRBETRIQ · Otezla · Ozempic · PREMARIN · PREVNAR 13 · QULIPTA · Repatha · Rybelsus · TRELEGY ELLIPTA · UBRELVY · VESICARE · VRAYLAR · WATCHMAN FLX · XARELTO · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a family medicine in North Port?
Compare family medicines in the North Port area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
268
Per 100K population
59.7
County median income
$80,633
Nearest hospital
HCA FLORIDA ENGLEWOOD HOSPITAL
7.5 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Grigoras is a clinical cardiology specialist, with above-average Medicare volume (top 4% in FL), and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Grigoras experienced with prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or?
Based on Medicare claims data, Dr. Grigoras performed 1,042 prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Grigoras receive payments from pharmaceutical companies?
Yes. Dr. Grigoras received a total of $807 from 13 companies across 43 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Grigoras's costs compare to other family medicines in North Port?
Dr. Grigoras's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Grigoras) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →